NUK - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov NUK. Za polni dostop se PRIJAVITE.

1
zadetkov: 1
1.
  • Focusing and sustaining the... Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
    Weigelin, Bettina; Elixabet Bolaños; Alvaro Teijeira ... Proceedings of the National Academy of Sciences - PNAS, 06/2015, Letnik: 112, Številka: 24
    Journal Article
    Recenzirano
    Odprti dostop

    Cancer immunotherapy is undergoing significant progress due to recent clinical successes by refined adoptive T-cell transfer and immunostimulatory monoclonal Ab (mAbs). B16F10-derived OVA-expressing ...
Celotno besedilo

PDF

Nalaganje filtrov